© POL.it 2003 CONGRESSI & CONVEGNI

INDICE
SEZIONE

INDICE
GENERALE

FEEDBACK
A POL.it

CERCA
IN POL.it

4th INTERNATIONAL FORUM ON MOOD

AND ANXIETY DISORDERS

NOVEMBER 19-21, 2003 - MONTE-CARLO

CHAIRMAN

Siegfried Kasper (Austria)

CO- CHAIRMAN

Stuart A. Montgomery (United Kingdom)

SCIENTIFIC ADVISERS

Christer Allgulander (Sweden)- A. Carlo Altamura (Italy) - David Baldwin (United Kingdom) - Graham Burrows (Australia) -Joseph Calabrese (USA) -Giovanni B. Cassano (Italy) - William F. Deakin (United Kingdom) - Koen Demyttenaere (Belgium) - Elias Eriksson (Sweden) - Teruhiko Higuchi (Japan) - Robert M.A. Hirschfeld (USA) - Sidney H. Kennedy (Canada) – Jean-Pierre Lépine (France) - Mario Maj (Italy) - Julien Mendlewicz (Belgium) - Hans-Jürgen Möller (Germany) - Franz Müller-Spahn (Switzerland) - Philippe H. Robert (France) - Alan F. Schatzberg (USA) - Dan J. Stein (South Africa) - Trisha Suppes (USA) - Eduard Vieta (Spain) - Lars von Knorring (Sweden) - Shigeto Yamawaki (Japan) - Joseph Zohar (Israel)

PRELIMINARY SCIENTIFIC PROGRAMME

New bipolar antidepressants

Are atypical antipsychotics antidepressants?

Switch rates of mania. Fact or fiction?

Long treatment of bipolar depression

Lamotrigine in bipolar depression

New treatment for resistant or refractory depression

Combination of antidepressants in resistant depression

Augmentation of SSRIs with antipsychotics

SNRIs in resistant depression

Algorithm in resistant depression

New Treatments for GAD

Fast onset of response in GAD

SSRIs and escitalopram in GAD

Pregabaline compared with other anxiolytics in GAD

Discontinuation symptoms in depression and anxiety disorder

Neuropeptides in Depression and Anxiety

Substance P antagonists in depression and CINV

Where are the CRF antagonists going?

Is the development program of CCK antagonists finished?

New results with nemifitide

Mood states in psychotic disorder

The treatment of psychotic mania

Is delusional depression a separate target?

The treatment of depression within schizophrenia

Suicide prevention in schizophrenia and schizoaffective disorders

Controlling Placebo

Placebo trials in depression and anxiety

Rater training, certification and other myths

Better monitoring, better patients

Severity increase assay sensitivity

Do we treat syndromes or diseases?

Epidemiology of depression and anxiety comorbidity

Neurobiology of depression and anxiety

SSRIs in depression, what’s new?

SSRIs in anxiety disorders

New results of antipsychotics in mania

Risperidone in mania

Quetiapine in mania

Olanzapine in mania

Ziprasidone in mania

SCIENTIFIC AND ORGANIZING SECRETARIAT

PUBLI CREATIONS – Partner of AIM

27, Bld d’Italie

98000 Monte-Carlo (Monaco)

Ph + 377 97973555 - Fax + 377 97973550

E-mail: ifmad@publicreations.com

Website: www.aim-internationalgroup.com/2003/ifmad

FORUM VENUE

Monte-Carlo Grand Hotel

12, Av. des Spélugues

98000 Monte-Carlo (Monaco)

COLLABORAZIONI

Dato l'alto numero degli avvenimenti congressuali che ogni anno vengono organizzati in Italia e nel mondo sarebbe oltremodo gradita la collaborazione dei lettori nella segnalazione "tempestiva" di congressi e convegni che cos potranno trovare spazio di presentazione nelle pagine della rubrica.
Il materiale concernente il programma congressuale e la sua presentazione scientico-organizzativa puo' essere mandato via posta elettronica possibilmente in formato WORD per un suo rapido trasferimento online

Scrivi alla REDAZIONE DI POL.it